Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging

被引:314
|
作者
Slemmer, J. E. [2 ]
Shacka, J. J. [3 ,4 ]
Sweeney, M. I. [2 ]
Weber, J. T. [1 ,5 ]
机构
[1] Mem Univ Newfoundland, Sch Pharm, Hlth Sci Ctr, St John, NF A1B 3V6, Canada
[2] Univ Prince Edward Isl, Dept Biol, Charlottetown, PE C1A 4P3, Canada
[3] Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA
[4] Birmingham VA Med Ctr, Dept Vet Affairs, Birmingham, AL USA
[5] Mem Univ Newfoundland, Fac Med, Div Basic Med Sci, St John, NF A1B 3V6, Canada
关键词
anthocyanins; natural products; NXY-059; oxidative stress; oxyresveratrol; reactive nitrogen species; reactive oxygen species; superoxide;
D O I
10.2174/092986708783497337
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The overproduction of reactive oxygen species (ROS) and reactive nitrogen species (RNS) is a common underlying mechanism of many neuropathologies, as they have been shown to damage various cellular components, including proteins, lipids and DNA. Free radicals, especially superoxide (O-2(center dot-)), and non-radicals, such as hydrogen peroxide (H2O2), can be generated in quantities large enough to overwhelm endogenous protective enzyme systems, such as superoxide dismutase (SOD) and reduced glutathione (GSH). Here we review the mechanisms of ROS and RNS production, and their roles in ischemia, traumatic brain injury and aging. In particular, we discuss several acute and chronic pharmacological therapies that have been extensively studied in order to reduce ROS/RNS loads in cells and the subsequent oxidative stress, so-called "free-radical scavengers." Although the overall aim has been to counteract the detrimental effects of ROS/RNS in these pathologies, success has been limited, especially in human clinical studies. This review highlights some of the recent successes and failures in animal and human studies by attempting to link a compound's chemical structure with its efficacy as a free radical scavenger. In particular, we demonstrate how antioxidants derived from natural products, as well as long-term dietary alterations, may prove to be effective scavengers of ROS and RNS.
引用
收藏
页码:404 / 414
页数:11
相关论文
共 50 条
  • [1] Peroxynitrite scavengers for the acute treatment of traumatic brain injury
    Hall, ED
    Kupina, NC
    Althaus, JS
    NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE, 1999, 890 : 462 - 468
  • [2] The use of antioxidants in the treatment of traumatic brain injury
    Venegoni, Whitney
    Shen, Qiuhua
    Thimmesch, Amanda R.
    Bell, Meredith
    Hiebert, John B.
    Pierce, Janet D.
    JOURNAL OF ADVANCED NURSING, 2017, 73 (06) : 1331 - 1338
  • [3] Antioxidants and free radical scavengers of natural origin
    Potterat, O
    CURRENT ORGANIC CHEMISTRY, 1997, 1 (04) : 415 - 440
  • [4] Antioxidants and free radical scavengers of natural origin
    Inst. Pharmacognosie P., Université de Lausanne, B.E.P., CH-1015 Lausanne, Switzerland
    Curr. Org. Chem., 4 (415-440):
  • [5] Free radical scavengers and antioxidants from Tagetes mendocina
    Schmeda-Hirschmann, G
    Tapia, A
    Theoduloz, C
    Rodríguez, J
    López, S
    Feresin, GE
    ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES, 2004, 59 (5-6): : 345 - 353
  • [7] Inhibition of platelet aggregation by free radical scavengers and antioxidants
    Karkabounas, S
    Karabetsos, D
    Evangelou, A
    Gogos, C
    Beka, A
    Sofis, G
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1922 - P1922
  • [8] Melatonin and tryptophan derivatives as free radical scavengers and antioxidants
    Reiter, RJ
    Tan, DX
    Cabrera, J
    D'Arpa, D
    TRYPTOPHAN, SEROTONIN AND MELATONIN: BASIC ASPECTS AND APPLICATIONS, 1999, 467 : 379 - 387
  • [9] Free radical scavengers and antioxidants from Baccharis grisebachii
    Tapia, A
    Rodriguez, J
    Theoduloz, C
    Lopez, S
    Feresin, GE
    Schmeda-Hirschmann, G
    JOURNAL OF ETHNOPHARMACOLOGY, 2004, 95 (2-3) : 155 - 161
  • [10] Neuroprotective Effects of Free Radical Scavengers in Stroke
    Chen X. Wang
    Ashfaq Shuaib
    Drugs & Aging, 2007, 24 : 537 - 546